Find research datasets worth reusing

A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov study NCT04090411. IPD Sharing: YES. Countries: 23. Publications: 1.

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

ClinicalTrials.gov study NCT02207244. IPD Sharing: Not stated. Countries: 9. Publications: 10.

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

ClinicalTrials.gov study NCT02138916. IPD Sharing: Not stated. Countries: 17. Publications: 2.

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

ClinicalTrials.gov study NCT04015518. IPD Sharing: NO. Countries: 15. Publications: 2.

A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

ClinicalTrials.gov study NCT03818035. IPD Sharing: YES. Countries: 2. Publications: 2.

Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)

ClinicalTrials.gov study NCT01045161. IPD Sharing: Not stated. Countries: 2. Publications: 1.

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov study NCT02260986. IPD Sharing: Not stated. Countries: 14. Publications: 23.

Study to Collect Information on How Well the Study Drug Naproxen Sodium Tablets Works Compared to Hydrocodone/Acetaminophen Tablets in Order to Relieve Pain in Participants Experiencing Moderate to Se

ClinicalTrials.gov study NCT04307940. IPD Sharing: NO. Countries: 1. Publications: 1.

Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

ClinicalTrials.gov study NCT03346434. IPD Sharing: Not stated. Countries: 4. Publications: 11.

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-

ClinicalTrials.gov study NCT04134728. IPD Sharing: YES. Countries: 15. Publications: 1.

Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU

ClinicalTrials.gov study NCT04010630. IPD Sharing: YES. Countries: 1. Publications: 2.

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

ClinicalTrials.gov study NCT04539964. IPD Sharing: NO. Countries: 1. Publications: 2.

Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe Pain

ClinicalTrials.gov study NCT01307020. IPD Sharing: Not stated. Countries: 6. Publications: 1.

Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation

ClinicalTrials.gov study NCT01732419. IPD Sharing: Not stated. Countries: 1. Publications: 2.

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

ClinicalTrials.gov study NCT01662063. IPD Sharing: Not stated. Countries: 2. Publications: 1.

A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Seve

ClinicalTrials.gov study NCT04647383. IPD Sharing: YES. Countries: 1. Publications: 3.

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

ClinicalTrials.gov study NCT01163253. IPD Sharing: YES. Countries: 36. Publications: 4.

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

ClinicalTrials.gov study NCT00988637. IPD Sharing: Not stated. Countries: 2. Publications: 2.

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

ClinicalTrials.gov study NCT03536884. IPD Sharing: YES. Countries: 11. Publications: 11.

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)

ClinicalTrials.gov study NCT04797650. IPD Sharing: NO. Countries: 7. Publications: 0.